Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026
Go back to Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026| (NASDAQ: IPSC) | Delayed: 2.17 +0.02 (0.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.15 | 52 Week High | $ | |||
| Open | $2.10 | 52 Week Low | $ | |||
| Day High | $2.18 | P/E | N/A | |||
| Day Low | $2.10 | EPS | $ | |||
| Volume | 519,932 | |||||

